Parkman Healthcare Partners LLC Deciphera Pharmaceuticals, Inc. Transaction History

Parkman Healthcare Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$13.58 - $17.36 $2.28 Million - $2.92 Million	168,205 Added 29.98%	729,230 $11.5 Million
Q4 2023 Feb 14, 2024	SELL	$10.11 - $16.54 $367,781 - $601,692	-36,378 Reduced 6.09%	561,025 $9.05 Million
Q3 2023 Nov 14, 2023	BUY	$12.46 - $15.48 $301,083 - $374,058	24,164 Added 4.22%	597,403 $7.6 Million
Q2 2023 Aug 11, 2023	BUY	$13.28 - $15.96 $1.08 Million - $1.3 Million	81,467 Added 16.57%	573,239 $8.07 Million
Q1 2023 May 12, 2023	BUY	$14.26 - $22.1 $2.09 Million - $3.25 Million	146,852 Added 42.58%	491,772 $7.6 Million
Q4 2022 Feb 13, 2023	BUY	$14.85 - $19.04 $638,965 - $819,253	43,028 Added 14.25%	344,920 $5.65 Million
Q3 2022 Nov 14, 2022	BUY	$12.38 - $20.23 $3.74 Million - $6.11 Million	301,892 New	301,892 $5.59 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Parkman Healthcare Partners LLC with notifications on news.